BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

337 related articles for article (PubMed ID: 33047901)

  • 1. Generation and initial characterization of novel tumour organoid models to study human pancreatic cancer-induced cachexia.
    Vaes RDW; van Dijk DPJ; Welbers TTJ; Blok MJ; Aberle MR; Heij L; Boj SF; Olde Damink SWM; Rensen SS
    J Cachexia Sarcopenia Muscle; 2020 Dec; 11(6):1509-1524. PubMed ID: 33047901
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human pancreatic tumour organoid-derived factors enhance myogenic differentiation.
    Vaes RDW; van Dijk DPJ; Farshadi EA; Olde Damink SWM; Rensen SS; Langen RC
    J Cachexia Sarcopenia Muscle; 2022 Apr; 13(2):1302-1313. PubMed ID: 35146962
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lipocalin-2 and neutrophil activation in pancreatic cancer cachexia.
    Deng M; Aberle MR; van Bijnen AAJHM; van der Kroft G; Lenaerts K; Neumann UP; Wiltberger G; Schaap FG; Olde Damink SWM; Rensen SS
    Front Immunol; 2023; 14():1159411. PubMed ID: 37006254
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of mononuclear cells and inflammatory cytokines in pancreatic cancer-related cachexia.
    Martignoni ME; Kunze P; Hildebrandt W; Künzli B; Berberat P; Giese T; Klöters O; Hammer J; Büchler MW; Giese NA; Friess H
    Clin Cancer Res; 2005 Aug; 11(16):5802-8. PubMed ID: 16115919
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumour-derived transforming growth factor-β signalling contributes to fibrosis in patients with cancer cachexia.
    Lima JDCC; Simoes E; de Castro G; Morais MRPT; de Matos-Neto EM; Alves MJ; Pinto NI; Figueredo RG; Zorn TMT; Felipe-Silva AS; Tokeshi F; Otoch JP; Alcantara P; Cabral FJ; Ferro ES; Laviano A; Seelaender M
    J Cachexia Sarcopenia Muscle; 2019 Oct; 10(5):1045-1059. PubMed ID: 31273954
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumour-derived leukaemia inhibitory factor is a major driver of cancer cachexia and morbidity in C26 tumour-bearing mice.
    Kandarian SC; Nosacka RL; Delitto AE; Judge AR; Judge SM; Ganey JD; Moreira JD; Jackman RW
    J Cachexia Sarcopenia Muscle; 2018 Dec; 9(6):1109-1120. PubMed ID: 30270531
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatic signal transducer and activator of transcription-3 signalling drives early-stage pancreatic cancer cachexia via suppressed ketogenesis.
    Arneson-Wissink PC; Mendez H; Pelz K; Dickie J; Bartlett AQ; Worley BL; Krasnow SM; Eil R; Grossberg AJ
    J Cachexia Sarcopenia Muscle; 2024 Jun; 15(3):975-988. PubMed ID: 38632714
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pancreatic Tumor Organoid-Derived Factors from Cachectic Patients Disrupt Contractile Smooth Muscle Cells.
    Vaes RDW; van Bijnen AA; Damink SWMO; Rensen SS
    Cancers (Basel); 2024 Jan; 16(3):. PubMed ID: 38339292
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MAP3K11/GDF15 axis is a critical driver of cancer cachexia.
    Lerner L; Tao J; Liu Q; Nicoletti R; Feng B; Krieger B; Mazsa E; Siddiquee Z; Wang R; Huang L; Shen L; Lin J; Vigano A; Chiu MI; Weng Z; Winston W; Weiler S; Gyuris J
    J Cachexia Sarcopenia Muscle; 2016 Sep; 7(4):467-82. PubMed ID: 27239403
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gut microbiota and short-chain fatty acid alterations in cachectic cancer patients.
    Ubachs J; Ziemons J; Soons Z; Aarnoutse R; van Dijk DPJ; Penders J; van Helvoort A; Smidt ML; Kruitwagen RFPM; Baade-Corpelijn L; Olde Damink SWM; Rensen SS
    J Cachexia Sarcopenia Muscle; 2021 Dec; 12(6):2007-2021. PubMed ID: 34609073
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of cancer cachexia-related factors in human cancer xenografts: an immunohistochemical analysis.
    Kamoshida S; Watanabe K; Suzuki M; Mizutani Y; Sakamoto K; Sugimoto Y; Oka T; Fukushima M; Tsutsumi Y
    Biomed Res; 2006 Dec; 27(6):275-81. PubMed ID: 17213683
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A systematic review examining the relationship between cytokines and cachexia in incurable cancer.
    Paval DR; Patton R; McDonald J; Skipworth RJE; Gallagher IJ; Laird BJ;
    J Cachexia Sarcopenia Muscle; 2022 Apr; 13(2):824-838. PubMed ID: 35080147
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circulating monocyte chemoattractant protein-1 (MCP-1) is associated with cachexia in treatment-naïve pancreatic cancer patients.
    Talbert EE; Lewis HL; Farren MR; Ramsey ML; Chakedis JM; Rajasekera P; Haverick E; Sarna A; Bloomston M; Pawlik TM; Zimmers TA; Lesinski GB; Hart PA; Dillhoff ME; Schmidt CR; Guttridge DC
    J Cachexia Sarcopenia Muscle; 2018 Apr; 9(2):358-368. PubMed ID: 29316343
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autocrine activin A signalling in ovarian cancer cells regulates secretion of interleukin 6, autophagy, and cachexia.
    Pettersen K; Andersen S; van der Veen A; Nonstad U; Hatakeyama S; Lambert C; Lach-Trifilieff E; Moestue S; Kim J; Grønberg BH; Schilb A; Jacobi C; Bjørkøy G
    J Cachexia Sarcopenia Muscle; 2020 Feb; 11(1):195-207. PubMed ID: 31436048
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Change of the growth hormone-insulin-like growth factor-I axis in patients with gastrointestinal cancer: related to tumour type and nutritional status.
    Huang Q; Nai YJ; Jiang ZW; Li JS
    Br J Nutr; 2005 Jun; 93(6):853-8. PubMed ID: 16022754
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lipopolysaccharide-induced hypothalamic inflammation in cancer cachexia-anorexia is amplified by tumour-derived prostaglandin E2.
    Li X; Holtrop T; Jansen FAC; Olson B; Levasseur P; Zhu X; Poland M; Schalwijk W; Witkamp RF; Marks DL; van Norren K
    J Cachexia Sarcopenia Muscle; 2022 Dec; 13(6):3014-3027. PubMed ID: 36303458
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modelling three-dimensional cancer-associated cachexia and therapy: The molecular basis and therapeutic potential of interleukin-6 transignalling blockade.
    Cosentino M; Forcina L; Zouhair M; Apa L; Genovese D; Boccia C; Rizzuto E; Musarò A
    J Cachexia Sarcopenia Muscle; 2023 Dec; 14(6):2550-2568. PubMed ID: 37727078
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inflammation-induced cholestasis in cancer cachexia.
    Thibaut MM; Sboarina M; Roumain M; Pötgens SA; Neyrinck AM; Destrée F; Gillard J; Leclercq IA; Dachy G; Demoulin JB; Tailleux A; Lestavel S; Rastelli M; Everard A; Cani PD; Porporato PE; Loumaye A; Thissen JP; Muccioli GG; Delzenne NM; Bindels LB
    J Cachexia Sarcopenia Muscle; 2021 Feb; 12(1):70-90. PubMed ID: 33350058
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exercise training decreases adipose tissue inflammation in cachectic rats.
    Lira FS; Yamashita AS; Rosa JC; Koyama CH; Caperuto EC; Batista ML; Seelaender MC
    Horm Metab Res; 2012 Feb; 44(2):91-8. PubMed ID: 22266827
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IL-6 mediated JAK/STAT3 signaling pathway in cancer patients with cachexia.
    Eskiler GG; Bezdegumeli E; Ozman Z; Ozkan AD; Bilir C; Kucukakca BN; Ince MN; Men AY; Aktas O; Horoz YE; Akpinar D; Genc I; Kaleli S
    Bratisl Lek Listy; 2019; 66(11):819-826. PubMed ID: 31747761
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.